FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raymond Anton

Research Profile

Disorders

Activities & Behaviors

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Joseph P Schacht; Patrick K Randall; Raymond F Anton; Scott Henderson; Xingbao Li; Donald L. Myrick
Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics.
Joseph P Schacht; Konstantin Voronin; Patrick K Randall; Raymond F Anton; Scott Henderson; Xingbao Li; Donald L. Myrick
Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Huiping Zhang; Hongyu Zhao; Wei Zheng; Raymond F Anton; Aryeh I Herman; Henry R Kranzler; Joel Gelernter
Array-based profiling of DNA methylation changes associated with alcohol dependence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raymond Anton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joseph P Schacht; Patrick K Randall; Raymond F Anton; Scott Henderson; Xingbao Li; Donald L. Myrick
Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics.
Psychopharmacology 2013;227(4):627-37.
2013: Joseph P Schacht; Konstantin Voronin; Patrick K Randall; Raymond F Anton; Scott Henderson; Xingbao Li; Donald L. Myrick
Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013;38(3):414-22.
2013: Huiping Zhang; Hongyu Zhao; Wei Zheng; Raymond F Anton; Aryeh I Herman; Henry R Kranzler; Joel Gelernter
Array-based profiling of DNA methylation changes associated with alcohol dependence.
Alcoholism, clinical and experimental research 2013;37 Suppl 1():E108-15.
2013: Joseph P Schacht; Raymond F Anton; Donald L. Myrick
Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review.
Addiction biology 2013;18(1):121-33.
2012: Raymond F Anton; Donald L. Myrick; Patrick K Randall; Konstantin K Voronin; Abraham Tiffany
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
Alcoholism, clinical and experimental research 2012;36(11):2000-7.
2012: Huiping Zhang; Raymond F Anton; Aryeh I Herman; Henry R Kranzler; Arthur A Simen; Joel Gelernter
Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence.
Journal of human genetics 2012;57(10):670-5.
2012: Chupong Ittiwut; Henry R Kranzler; Roger D Weiss; Bao-Zhu Yang; Raymond F Anton; Jonathan Covault; Lindsay A Farrer; Rungnapa Hirunsatit; Joel Gelernter
GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans.
Alcoholism, clinical and experimental research 2012;36(4):588-93.
2012: Huiping Zhang; Raymond F Anton; Henry R Kranzler; Fan Wang; Joel Gelernter
Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses.
Behavioral and brain functions : BBF 2012;8():23.
2011: Henry R Kranzler; Elliot C Nelson; Raymond F Anton; Jonathan Covault; Lindsay Farrer; Richard Feinn; Joel Gelernter
A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2011;156B(8):960-8.
2011: Joseph P Schacht; L Randolph Waid; Tara M Wright; Alicia M Baros; Patricia K Latham; Donald L. Myrick; Patrick K Randall; Raymond F Anton
Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
Alcoholism, clinical and experimental research 2011;35(11):2030-8.
2011: Kara Douglas; Lindsay Farrer; Joel Gelernter; Raymond F Anton; Albert J Arias; Grace Chan; James Poling; Henry R Kranzler
5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder.
Psychiatric genetics 2011;21(5):240-8.
2011: Pingxing Xie; Hongyu Zhao; Raymond F Anton; Kelly P Cosgrove; Lindsay A Farrer; Henry R Kranzler; Michael Krauthammer; John H Krystal; David Oslin; Marina R Picciotto; Joel Gelernter
Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence.
Biological psychiatry 2011;70(6):528-36.
2011: Raymond F Anton; Alicia M Baros; Patricia K Latham; Hugh Myrick; L Randolph Waid; Tara M Wright; Patrick K Randall
Gabapentin combined with naltrexone for the treatment of alcohol dependence.
The American journal of psychiatry 2011;168(7):709-17.
2011: Donghong Cui; Huiping Zhang; Bao-Zhu Yang; Jennifer B Listman; Dawei Li; Lawrence H Price; Linda L Carpenter; Audrey R Tyrka; Raymond F Anton; Henry R Kranzler; Joel Gelernter
Variation in NGFB is associated with primary affective disorders in women.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2011;156B(4):401-12.
2011: Joseph P Schacht; Raymond F Anton; Patrick K Randall; Xingbao Li; Scott Henderson; Donald L. Myrick
Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach.
NeuroImage 2011;56(1):61-8.
2011: Aryeh I Herman; Tamlin S Conner; Raymond F Anton; Joel Gelernter; Henry R Kranzler; Jonathan Covault
Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics.
Addiction biology 2011;16(1):124-32.
2010: Scott H Stewart; Susana Comte-Walters; Emily Bowen; Raymond F Anton
Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series.
Alcoholism, clinical and experimental research 2010;34(11):1956-60.
2010: Richard Sherva; Henry R Kranzler; Yi Yu; Mark W Logue; James Poling; Albert J Arias; Raymond F Anton; David Oslin; Lindsay A Farrer; Joel Gelernter
Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(9):1921-31.
2010: Pingxing Xie; Henry R Kranzler; James Poling; Murray B Stein; Raymond F Anton; Lindsay A Farrer; Joel Gelernter
Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(8):1684-92.
2010: Raymond F Anton
Editorial commentary: alcohol biomarker papers.
Alcoholism, clinical and experimental research 2010;34(6):939-40.
2010: Derick E Vergne; Raymond F Anton
Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence.
CNS & neurological disorders drug targets 2010;9(1):50-4.
2010: Kara R Douglas; Grace Chan; Joel Gelernter; Albert J Arias; Raymond F Anton; Roger D Weiss; Kathleen Brady; James Poling; Lindsay Farrer; Henry R Kranzler
Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders.
Addictive behaviors 2010;35(1):7-13.
2009: Mark J Niciu; Grace Chan; Joel Gelernter; Albert J Arias; Kara Douglas; Roger Weiss; Raymond F Anton; Lindsay Farrer; Joseph F Cubells; Henry R Kranzler
Subtypes of major depression in substance dependence.
Addiction (Abingdon, England) 2009;104(10):1700-9.
2009: Donald L. Myrick; Robert Malcolm; Patrick K Randall; Elizabeth Boyle; Raymond F Anton; Howard C Becker; Carrie L Randall
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
Alcoholism, clinical and experimental research 2009;33(9):1582-8.
2009: Raymond F Anton; Donald L. Myrick; Alicia M Baros; Patricia K Latham; Patrick K Randall; Tara M. Wright; Scott H Stewart; Randy Waid; Robert Malcolm
Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.
Journal of clinical psychopharmacology 2009;29(4):334-42.
2009: Huiping Zhang; Henry R Kranzler; Roger D Weiss; Xingguang Luo; Kathleen T Brady; Raymond F Anton; Lindsay A Farrer; Joel Gelernter
Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies.
Biological psychiatry 2009;66(2):128-36.
2009: Peter M Miller; Jeffrey Cluver; Raymond F Anton
A useful test for monitoring alcohol use.
Behavioral healthcare 2009;29(6):38, 40.
2009: Lingjun Zuo; Xingguang Luo; Jennifer B Listman; Henry R Kranzler; Shuang Wang; Raymond F Anton; Hilary P Blumberg; Murray B Stein; Godfrey D Pearlson; Jonathan Covault; Dennis S Charney; Daniel P van Kammen; Lawrence H Price; Jaakko Lappalainen; Joyce Cramer; John H Krystal; Joel Gelernter
Population admixture modulates risk for alcohol dependence.
Human genetics 2009;125(5-6):605-13.
2009: Henry R Kranzler; Joel Gelernter; Raymond F Anton; Albert J Arias; Aryeh Herman; Hongyu Zhao; Linda Burian; Jonathan Covault
Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence.
Alcoholism, clinical and experimental research 2009;33(5):925-30.
2009: Joseph S Locastro; Marston Youngblood; Ron A Cisler; Margaret E Mattson; Allen Zweben; Raymond F Anton; Dennis Donovan
Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study.
Journal of studies on alcohol and drugs 2009;70(2):186-96.
2009: Lindsay A Farrer; Henry R Kranzler; Yi Yu; Roger D Weiss; Kathleen T Brady; Raymond F Anton; Joseph F Cubells; Joel Gelernter
Association of variants in MANEA with cocaine-related behaviors.
Archives of general psychiatry 2009;66(3):267-74.
2009: Gabor Oroszi; Raymond F Anton; Stephanie O'Malley; Robert Swift; Helen M Pettinati; David J Couper; Qiaoping Yuan; David Goldman
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.
Alcoholism, clinical and experimental research 2009;33(3):383-93.
2009: Scott H Stewart; Gabor Oroszi; Patrick K Randall; Raymond F Anton
COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study.
American journal of hypertension 2009;22(1):87-91.
2008: Konstantin Voronin; Patrick K Randall; Donald L. Myrick; Raymond F Anton
Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.
Alcoholism, clinical and experimental research 2008;32(11):1954-61.
2008: Scott H Stewart; Patricia K Latham; Peter M Miller; Patrick K Randall; Raymond F Anton
Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study.
Addiction (Abingdon, England) 2008;103(10):1622-8.
2008: Raymond F Anton
Naltrexone for the management of alcohol dependence.
The New England journal of medicine 2008;359(7):715-21.
2008: Bankole A Johnson; Norman Rosenthal; Julie A Capece; Frank Wiegand; Lian Mao; Karen Beyers; Amy McKay; Nassima Ait-Daoud; Giovanni Addolorato; Raymond F Anton; Domenic A Ciraulo; Henry R Kranzler; Karl Mann; Stephanie S O'Malley; Robert Swift
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.
Archives of internal medicine 2008;168(11):1188-99.
2008: Raymond F Anton
Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence.
Pharmacogenomics 2008;9(6):655-8.
2008: A M Baros; Patricia K Latham; Raymond F Anton
Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?
Alcoholism, clinical and experimental research 2008;32(5):771-6.
2008: Donald L. Myrick; Raymond F Anton; Xingbao Li; Scott Henderson; Patrick K Randall; Konstantin Voronin
Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.
Archives of general psychiatry 2008;65(4):466-75.
2008: A M Baros; Tara M. Wright; Patricia K Latham; Peter M Miller; Raymond F Anton
Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
Alcohol and alcoholism (Oxford, Oxfordshire) 2008;43(2):192-7.
2008: Jonathan Covault; Joel Gelernter; Kevin Jensen; Raymond F Anton; Henry R Kranzler
Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(4):837-48.
2008: Raymond F Anton; Gabor Oroszi; Stephanie O'Malley; David J Couper; Robert Swift; Helen M Pettinati; David Goldman
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
Archives of general psychiatry 2008;65(2):135-44.
2008: Raymond F Anton; Henry Kranzler; Christopher Breder; Ronald N Marcus; William H Carson; Jian Han
A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Journal of clinical psychopharmacology 2008;28(1):5-12.
2008: Xingguang Luo; Lingjun Zuo; Henry R Kranzler; Shuang Wang; Raymond F Anton; Joel Gelernter
Recessive genetic mode of an ADH4 variant in substance dependence in African-Americans: A model of utility of the HWD test.
Behavioral and brain functions : BBF 2008;4():42.
2008: Dennis Donovan; Raymond F Anton; William R Miller; Richard Longabaugh; James D Hosking; Marston Youngblood
Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
Journal of studies on alcohol and drugs 2008;69(1):5-13.
2007: Lance O Bauer; Jonathan Covault; Ofer Harel; Sourish Das; Joel Gelernter; Raymond F Anton; Henry R Kranzler
Variation in GABRA2 predicts drinking behavior in project MATCH subjects.
Alcoholism, clinical and experimental research 2007;31(11):1780-7.
2007: Bankole A Johnson; Norman Rosenthal; Julie A Capece; Frank Wiegand; Lian Mao; Karen Beyers; Amy McKay; Nassima Ait-Daoud; Raymond F Anton; Domenic A Ciraulo; Henry R Kranzler; Karl Mann; Stephanie S O'Malley; Robert Swift
Topiramate for treating alcohol dependence: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2007;298(14):1641-51.
2007: Herbert D Kleber; Roger D Weiss; Raymond F Anton; Tony P George; Shelly F Greenfield; Thomas R Kosten; Charles P O'Brien; Bruce J Rounsaville; Eric C Strain; Douglas M Ziedonis; Grace Hennessy; Hilary Smith Connery; John S McIntyre; Sara C Charles; Daniel J Anzia; Ian A Cook; Molly T Finnerty; Bradley R Johnson; James E Nininger; Paul Summergrad; Sherwyn M Woods; Joel Yager; Robert Pyles; C Deborah Cross; Roger Peele; John P D Shemo; Lawrence Lurie; Roger Dale Walker; Mary Ann Barnovitz; Sheila Hafter Gray; Sunil Saxena; Tina Tonnu; Robert Kunkle; Amy B Albert; Laura J Fochtmann; Claudia Hart; Darrel Regier
Treatment of patients with substance use disorders, second edition. American Psychiatric Association.
The American journal of psychiatry 2007;164(4 Suppl):5-123.
2007: Alicia M Baros; Patricia K Latham; Darlene Moak; Konstantin Voronin; Raymond F Anton
What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
Alcoholism, clinical and experimental research 2007;31(4):596-603.
2007: Donald L. Myrick; Raymond F Anton; Konstantin Voronin; Wei Wang; Scott Henderson
A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
Alcoholism, clinical and experimental research 2007;31(2):221-7.
2007: Jan-Olof Jeppsson; Torsten Arndt; François Schellenberg; Jos P M Wielders; Raymond F Anton; John B Whitfield; Anders Helander
Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(4):558-62.
2006: Raymond F Anton; Marston Youngblood
Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study.
Alcoholism, clinical and experimental research 2006;30(11):1878-83.
2006: Kathleen T Brady; Angela E Waldrop; Aimee L McRae; Sudie E Back; Michael E Saladin; Himanshu P Upadhyaya; Raymond F Anton; Patrick K Randall
The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response.
Journal of studies on alcohol 2006;67(5):700-6.
2006: Herbert D Kleber; Roger D Weiss; Raymond F Anton; Bruce J Rounsaville; Tony P George; Eric C Strain; Shelly F Greenfield; Douglas M Ziedonis; Thomas R Kosten; Grace Hennessy; Charles P O'Brien; Hilary Smith Connery; John S McIntyre; Sara C Charles; Daniel J Anzia; James E Nininger; Ian A Cook; Paul Summergrad; Molly T Finnerty; Sherwyn M Woods; Bradley R Johnson; Joel Yager; Robert Pyles; Lawrence Lurie; C Deborah Cross; Roger Dale Walker; Roger Peele; Mary Ann Barnovitz; Sheila Hafter Gray; John P D Shemo; Sunil Saxena; Tina Tonnu; Robert Kunkle; Amy B Albert; Laura J Fochtmann; Claudia Hart; Darrel Regier
Treatment of patients with substance use disorders, second edition. American Psychiatic Association.
The American journal of psychiatry 2006;163(8 Suppl):5-82.
2006: Kathleen T Brady; Sudie E Back; Angela E Waldrop; Aimee L McRae; Raymond F Anton; Himanshu P Upadhyaya; Michael E Saladin; Patrick K Randall
Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder.
Alcoholism, clinical and experimental research 2006;30(6):938-46.
2006: Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David J Couper; Dennis Donovan; David Gastfriend; James D Hosking; Bankole A Johnson; Joseph S Locastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren Williams; Allen Zweben
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2006;295(17):2003-17.
2006: Peter M Miller; Claudia Spies; Tim Neumann; Martin A Javors; A M Hoyumpa; John D Roache; Amy Webb; Maryam Kashi; Francis E Sharkey; Raymond F Anton; Brent M Egan; Jan Basile; Shaun Nguyen; Michael F Fleming; Kathryn Sullivan Dillie
Alcohol biomarker screening in medical and surgical settings.
Alcoholism, clinical and experimental research 2006;30(2):185-93.
2005: Deborah Deas; M P H Kim May; Carrie L Randall; Natalie Johnson; Raymond F Anton
Naltrexone treatment of adolescent alcoholics: an open-label pilot study.
Journal of child and adolescent psychopharmacology 2005;15(5):723-8.
2005: Raymond F Anton; Darlene Moak; Patricia K Latham; L Randolph Waid; Donald L. Myrick; Konstantin Voronin; Angelica Thevos; Wei Wang; Robert F Woolson
Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.
Journal of clinical psychopharmacology 2005;25(4):349-57.
2005: Raymond F Anton; Carrie L Randall
Measurement and choice of drinking outcome variables in the COMBINE Study.
Journal of studies on alcohol. Supplement 2005;(15):104-9; discussion 92-3.
2005: David Goldman; Gabor Oroszi; Stephanie O'Malley; Raymond F Anton
COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.
Journal of studies on alcohol. Supplement 2005;(15):56-64; discussion 33.
2005: James D Hosking; Ron A Cisler; David J Couper; David Gastfriend; Daniel R Kivlahan; Raymond F Anton
Design and analysis of trials of combination therapies.
Journal of studies on alcohol. Supplement 2005;(15):34-42; discussion 33.
2005: Christer Alling; Jonathan Chick; Raymond F Anton; R D Mayfield; M Salaspuro; Anders Helander; R A Harris
Revealing alcohol abuse: to ask or to test?
Alcoholism, clinical and experimental research 2005;29(7):1257-63.
2005: Peter M Miller; Raymond F Anton; Brent M Egan; Jan Basile; Shaun Nguyen
Excessive alcohol consumption and hypertension: clinical implications of current research.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(6):346-51.
2005: Kathleen T Brady; Susan C Sonne; Raymond F Anton; Carrie L Randall; Sudie E Back; Kit N Simpson
Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.
Alcoholism, clinical and experimental research 2005;29(3):395-401.
2004: Therese K Killeen; Kathleen T Brady; Paul B Gold; Kit N Simpson; Richard A Faldowski; Clare Tyson; Raymond F Anton
Effectiveness of naltrexone in a community treatment program.
Alcoholism, clinical and experimental research 2004;28(11):1710-7.
2004: Donald L. Myrick; Raymond F Anton
Recent advances in the pharmacotherapy of alcoholism.
Current psychiatry reports 2004;6(5):332-8.
2004: David J Drobes; Raymond F Anton; Suzanne E Thomas; Konstantin Voronin
Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
Alcoholism, clinical and experimental research 2004;28(9):1362-70.
2004: Michael F Fleming; Raymond F Anton; Claudia D Spies
A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.
Alcoholism, clinical and experimental research 2004;28(9):1347-55.
2004: Peter M Miller; Raymond F Anton
Biochemical alcohol screening in primary health care.
Addictive behaviors 2004;29(7):1427-37.
2004: Raymond F Anton; Helen M Pettinati; Allen Zweben; Henry R Kranzler; Bankole Johnson; Michael J Bohn; Mary E McCaul; Robert Anthenelli; Ihsan Salloum; Gantt Galloway; James C Garbutt; Robert Swift; David Gastfriend; Antero Kallio; Sakari Karhuvaara
A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence.
Journal of clinical psychopharmacology 2004;24(4):421-8.
2004: Lawrence A Labbate; Susan C Sonne; Carrie L Randal; Raymond F Anton; Kathleen T Brady
Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?
Comprehensive psychiatry 2004;45(4):304-10.
2004: Peter M Miller; Steven M Ornstein; Paul Nietert; Raymond F Anton
Self-report and biomarker alcohol screening by primary care physicians: the need to translate research into guidelines and practice.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(4):325-8.
2004: John M Littleton; Philippe De Witte; Raye Litten; Gian Luigi Gessa; Rainer Spanagel; Henry R Kranzler; Philippe Lehert; Bankole Johnson; John Saunders; Mats Berglund; Adron Harris; Raymond F Anton; Karl Mann
Challenges to medications development in treating alcohol dependence: an international perspective.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(4):271-5.
2004: Suzanne E Thomas; David J Drobes; Konstantin Voronin; Raymond F Anton
Following alcohol consumption, nontreatment-seeking alcoholics report greater stimulation but similar sedation compared with social drinkers.
Journal of studies on alcohol 2004;65(3):330-5.
2004: Raymond F Anton; David J Drobes; Konstantin Voronin; Ramon Durazo-Avizu; Darlene Moak
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking.
Psychopharmacology 2004;173(1-2):32-40.
2004: Donald L. Myrick; Raymond F Anton; Xingbao Li; Scott Henderson; David J Drobes; Konstantin Voronin; Mark Stork George
Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(2):393-402.
2003: Darlene Moak; Raymond F Anton; Patricia K Latham; Konstantin Voronin; Randolph L Waid; Ramon Durazo-Arvizu
Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
Journal of clinical psychopharmacology 2003;23(6):553-62.
2003: Maggie Nellissery; Richard Feinn; Jonathan Covault; Joel Gelernter; Raymond F Anton; Helen M Pettinati; Darlene Moak; Timothy Mueller; Henry R Kranzler
Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics.
Alcoholism, clinical and experimental research 2003;27(9):1402-8.
2003: David J Drobes; Raymond F Anton; Suzanne E Thomas; Konstantin Voronin
A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(4):755-64.
2003: David Gastfriend; Amy Rubin; Estee Sharon; Winston M Turner; Raymond F Anton; Dennis Donovan; Terence Gorski; G Alan Marlatt; Steven Maisto; Terry K Schultz; Gerald D Shulman
New constructs and assessments for relapse and continued use potential in the ASAM Patient Placement Criteria.
Journal of addictive diseases 2003;22 Suppl 1():95-111.
2003: Raymond F Anton; Robert Swift
Current pharmacotherapies of alcoholism: a U.S. perspective.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2003;12 Suppl 1():S53-68.
2003: John P Allen; Raymond F Anton
Biomarkers as aids to identification of relapse in alcoholic patients.
Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 2003;16():25-38.
2002: Deborah Deas; James S Roberts; Carrie L Randall; Raymond F Anton
Confirmatory analysis of the adolescent obsessive compulsive drinking scale (A-OCDS): a measure of 'craving' and problem drinking in adolescents/young adults.
Journal of the National Medical Association 2002;94(10):879-87.
2002: Margaret Rukstalis; Kevin G Lynch; David W Oslin; Helen M Pettinati; Suzanne M Anderson; Joseph Robert Volpicelli; Raymond F Anton
Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment.
Alcoholism, clinical and experimental research 2002;26(10):1539-44.
2002: Carol A Shively; J Koudy Williams; Kathy E. Laber-Laird; Raymond F Anton
Depression and coronary artery atherosclerosis and reactivity in female cynomolgus monkeys.
Psychosomatic medicine 2002;64(5):699-706.
2002: Raymond F Anton; Charles Lieber; Boris Tabakoff
Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.
Alcoholism, clinical and experimental research 2002;26(8):1215-22.
2002: Robert Malcolm; Donald L. Myrick; John Martin Roberts; Wei Wang; Raymond F Anton; James C Ballenger
The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.
Journal of general internal medicine 2002;17(5):349-55.
2002: Robert Malcolm; Donald L. Myrick; James Roberts; Wei Wang; Raymond F Anton
The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2002;11(2):141-50.
2001: Raymond F Anton
Naltrexone for alcohol dependence: comments on Morris et al. (2001).
Addiction (Abingdon, England) 2001;96(12):1855.
2001: Andrea F DiMartini; Nancy Day; T Lane; Amy T Beisler; Mary Amanda Dew; Raymond F Anton
Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease.
Alcoholism, clinical and experimental research 2001;25(12):1729-33.
2001: Raymond F Anton
Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here?
Alcohol (Fayetteville, N.Y.) 2001;25(3):185-8.
2001: Raymond F Anton; C Dominick; Michael R Bigelow; C Westby
Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase.
Clinical chemistry 2001;47(10):1769-75.
2001: Donald L. Myrick; S Henderson; Raymond F Anton
Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study.
Alcoholism, clinical and experimental research 2001;25(9):1330-4.
2001: D E Johnson; Jeffery N Epstein; L Randolph Waid; Patricia K Latham; Konstantin Voronin; Raymond F Anton
Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2001;16(6):587-604.
2001: Karl Mann; Ingrid Agartz; C Harper; Susan E Shoaf; Robert R Rawlings; Reza Momenan; Daniel W Hommer; A Pfefferbaum; Edith Sullivan; Raymond F Anton; David J Drobes; Mark Stork George; Roland Bares; Hans-Jürgen Machulla; Götz Mundle; Matthias Reimold; Andreas Heinz
Neuroimaging in alcoholism: ethanol and brain damage.
Alcoholism, clinical and experimental research 2001;25(5 Suppl ISBRA):104S-109S.
2001: Raj Lakshman; M Tsutsumi; P Ghosh; S Takase; Helen Anni; O Nikolaeva; Yedy Israel; Raymond F Anton; O M Lesch; A Helender; G Eriksson; J O Jeppson; Philippe Marmillot; Manjunath N Rao
Alcohol biomarkers: clinical significance and biochemical basis.
Alcoholism, clinical and experimental research 2001;25(5 Suppl ISBRA):67S-70S.
2001: Mark Stork George; Raymond F Anton; C Bloomer; Charlotte Teneback; David J Drobes; Jeffrey P Lorberbaum; Ziad Nahas; Diana J Vincent
Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues.
Archives of general psychiatry 2001;58(4):345-52.
2001: Deborah Deas; John Martin Roberts; Carrie L Randall; Raymond F Anton
Adolescent Obsessive-Compulsive Drinking Scale: an assessment tool for problem drinking.
Journal of the National Medical Association 2001;93(3):92-103.
2001: Barbara A Flannery; A J Roberts; N Cooney; Robert Swift; Raymond F Anton; Damaris J Rohsenow
The role of craving in alcohol use, dependence, and treatment.
Alcoholism, clinical and experimental research 2001;25(2):299-308.
2001: Raymond F Anton; Darlene Moak; Patricia K Latham; L Randolph Waid; Robert Malcolm; James K Dias; James S Roberts
Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism.
Journal of clinical psychopharmacology 2001;21(1):72-7.
2001: Raymond F Anton
Pharmacologic approaches to the management of alcoholism.
The Journal of clinical psychiatry 2001;62 Suppl 20():11-7.
2001: T Brouette; Raymond F Anton
Clinical review of inhalants.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2001;10(1):79-94.
2000: Robert Malcolm; James S Roberts; Wei Wang; Donald L. Myrick; Raymond F Anton
Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification.
Alcohol (Fayetteville, N.Y.) 2000;22(3):159-64.
2000: Jonathan Chick; Raymond F Anton; K Checinski; R Croop; D Colin Drummond; R Farmer; D Labriola; J Marshall; J Moncrieff; Marsha Y Morgan; T Peters; Bruce Ritson
A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
Alcohol and alcoholism (Oxford, Oxfordshire) 2000;35(6):587-93.
2000: Raymond F Anton
Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale.
Addiction (Abingdon, England) 2000;95 Suppl 2():S211-7.
2000: Robert Malcolm; Daniel K Kajdasz; Janice Herron; Raymond F Anton; Kathleen T Brady
A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence.
Drug and alcohol dependence 2000;60(2):161-8.
2000: David J Drobes; Raymond F Anton
Drinking in alcoholics following an alcohol challenge research protocol.
Journal of studies on alcohol 2000;61(2):220-4.
2000: Donald L. Myrick; Raymond F Anton
Clinical management of alcohol withdrawal.
CNS spectrums 2000;5(2):22-32.
2000: Robert Malcolm; J E Herron; Raymond F Anton; John Martin Roberts; J Moore
Recurrent detoxification may elevate alcohol craving as measured by the Obsessive Compulsive Drinking scale.
Alcohol (Fayetteville, N.Y.) 2000;20(2):181-5.
2000: Thomas F Babor; K Steinberg; Raymond F Anton; FK Del Boca
Talk is cheap: measuring drinking outcomes in clinical trials.
Journal of studies on alcohol 2000;61(1):55-63.
1999: Raymond F Anton; Darlene Moak; L Randolph Waid; Patricia K Latham; Robert Malcolm; James K Dias
Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
The American journal of psychiatry 1999;156(11):1758-64.
1999: James S Roberts; Raymond F Anton; Patricia K Latham; Darlene Moak
Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale.
Alcoholism, clinical and experimental research 1999;23(9):1484-91.
1999: Raymond F Anton
Alcohol craving--a renaissance.
Alcoholism, clinical and experimental research 1999;23(8):1287-8.
1999: Mark Stork George; C C Tenebäck; Robert Malcolm; J Moore; LE Stallings; Kenneth M. Spicer; Raymond F Anton; James C Ballenger
Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period.
Alcoholism, clinical and experimental research 1999;23(6):1077-84.
1999: Michael David Horner; L Randolph Waid; D E Johnson; Patricia K Latham; Raymond F Anton
The relationship of cognitive functioning to amount of recent and lifetime alcohol consumption in outpatient alcoholics.
Addictive behaviors 1999;24(3):449-53.
1999: Raymond F Anton
What is craving? Models and implications for treatment.
Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism 1999;23(3):165-73.
1999: J P Allen; P Sillamaukee; Raymond F Anton
Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism.
Alcoholism, clinical and experimental research 1999;23(1):115-20.
1999: Robert Malcolm; Raymond F Anton; S E Conrad; S Sutherland
Carbohydrate-deficient transferrin and alcohol use in medical examiner cases.
Alcohol (Fayetteville, N.Y.) 1999;17(1):7-11.
1998: Raymond F Anton; Robert Stout; James S Roberts; J P Allen
The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics.
Alcoholism, clinical and experimental research 1998;22(7):1456-62.
1998: J Yeastedt; Linda La Grange; Raymond F Anton
Female alcoholic outpatients and female college students: a correlational study of self-reported alcohol consumption and carbohydrate-deficient transferrin levels.
Journal of studies on alcohol 1998;59(5):555-9.
1998: Donald L. Myrick; Raymond F Anton
Treatment of alcohol withdrawal.
Alcohol health and research world 1998;22(1):38-43.
1998: Darlene Moak; Raymond F Anton; Patricia K Latham
Further validation of the Obsessive-Compulsive Drinking Scale (OCDS). Relationship to alcoholism severity.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1998;7(1):14-23.
1997: D E Johnson; L Randolph Waid; Raymond F Anton
Childhood hyperactivity, gender, and Cloninger's personality dimensions in alcoholics.
Addictive behaviors 1997;22(5):649-53.
1997: Raymond F Anton; Henry R Kranzler; J P McEvoy; Darlene Moak; R Bianca
A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.
Psychopharmacology 1997;131(2):123-9.
1997: Carol A Shively; Kathy E. Laber-Laird; Raymond F Anton
Behavior and physiology of social stress and depression in female cynomolgus monkeys.
Biological psychiatry 1997;41(8):871-82.
1997: John P Allen; Joanne Fertig; Raye Z Litten; Pekka Sillanaukee; Raymond F Anton
Proposed recommendations for research on biochemical markers for problematic drinking.
Alcoholism, clinical and experimental research 1997;21(2):244-7.
1996: B A Johnson; Donald R Jasinski; Gantt Galloway; H Kranzler; R Weinreib; Raymond F Anton; B J Mason; M J Bohn; H M Pettinati; R Rawson; C Clyde
Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group.
Psychopharmacology 1996;128(2):206-15.
1996: Raymond F Anton
Pharmacotherapy of alcoholism--10 years of progress.
Alcoholism, clinical and experimental research 1996;20(8 Suppl):172A-175A.
1996: Raymond F Anton
The use of carbohydrate deficient transferrin as an indicator of alcohol consumption during treatment and follow-up.
Alcoholism, clinical and experimental research 1996;20(8 Suppl):54A-56A.
1996: Raymond F Anton
New methodologies for pharmacological treatment trials for alcohol dependence.
Alcoholism, clinical and experimental research 1996;20(7 Suppl):3A-9A.
1996: B Adinoff; Raymond F Anton; M Linnoila; Alessandro Guidotti; Charles Nemeroff; Garth Bissette
Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(3):288-95.
1996: Raymond F Anton; Darlene Moak; Patricia K Latham
Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study.
Alcoholism, clinical and experimental research 1996;20(5):841-6.
1996: Raymond F Anton
Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1996;1():43-53.
1996: Darlene Moak; Raymond F Anton
Alcohol-related seizures and the kindling effect of repeated detoxifications: the influence of cocaine.
Alcohol and alcoholism (Oxford, Oxfordshire) 1996;31(2):135-43.
1996: Raymond F Anton
Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
Alcohol and alcoholism (Oxford, Oxfordshire) 1996;31 Suppl 1():43-53.
1996: Raymond F Anton; Darlene Moak; Patricia K Latham
The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.
Archives of general psychiatry 1996;53(3):225-31.
1995: P Bean; M S Sutphin; Y Liu; Raymond F Anton; T B Reynolds; Y Shoenfeld; James B Peter
Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies.
Clinical chemistry 1995;41(6 Pt 1):858-61.
1995: Kathleen T Brady; Susan C Sonne; Raymond F Anton; James C Ballenger
Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
The Journal of clinical psychiatry 1995;56(3):118-21.
1995: Raymond F Anton; Darlene Moak; Patricia K Latham
The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior.
Alcoholism, clinical and experimental research 1995;19(1):92-9.
1995: Linda La Grange; Raymond F Anton; S Garcia; C Herrbold
Carbohydrate-deficient transferrin levels in a female population.
Alcoholism, clinical and experimental research 1995;19(1):100-3.
1995: Raymond F Anton; H R Kranzler; R E Meyer
Neurobehavioral aspects of the pharmacotherapy of alcohol dependence.
Clinical neuroscience (New York, N.Y.) 1995;3(3):145-54.
1994: Henry R Kranzler; Raymond F Anton
Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.
Journal of consulting and clinical psychology 1994;62(6):1116-26.
1994: Gerard J Connors; John P Allen; Ned L Cooney; Carlo C Diclemente; J Scott Tonigan; Raymond F Anton
Assessment issues and strategies in alcoholism treatment matching research.
Journal of studies on alcohol. Supplement 1994;12():92-100.
1994: R K Fuller; Margaret E Mattson; John P Allen; Carrie L Randall; Raymond F Anton; Thomas F Babor
Multisite clinical trials in alcoholism treatment research: organizational, methodological and management issues.
Journal of studies on alcohol. Supplement 1994;12():30-7.
1994: Thomas F Babor; Richard Longabaugh; Allen Zweben; R K Fuller; Robert Stout; Raymond F Anton; Carrie L Randall
Issues in the definition and measurement of drinking outcomes in alcoholism treatment research.
Journal of studies on alcohol. Supplement 1994;12():101-11.
1994: E A Burch; Raymond F Anton; W H Carson
Mood congruent and incongruent psychotic depressions: are they the same?
Journal of affective disorders 1994;31(4):275-80.
1994: John P Allen; Raye Z Litten; Raymond F Anton; G M Cross
Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues.
Alcoholism, clinical and experimental research 1994;18(4):799-812.
1994: Raymond F Anton; Darlene Moak
Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences.
Alcoholism, clinical and experimental research 1994;18(3):747-54.
1994: Linda La Grange; Raymond F Anton; H Crow; S Garcia
A correlational study of carbohydrate-deficient transferrin values and alcohol consumption among Hispanic college students.
Alcoholism, clinical and experimental research 1994;18(3):653-6.
1994: Raymond F Anton; P Bean
Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared.
Clinical chemistry 1994;40(3):364-8.
1993: R B Lydiard; Raymond F Anton; T Cunningham
Interactions between sertraline and tricyclic antidepressants.
The American journal of psychiatry 1993;150(7):1125-6.
1993: Raymond F Anton; E A Burch
Response of psychotic depression subtypes to pharmacotherapy.
Journal of affective disorders 1993;28(2):125-31.
1992: Robert Malcolm; Raymond F Anton; Carrie L Randall; A Johnston; Kathleen T Brady; A Thevos
A placebo-controlled trial of buspirone in anxious inpatient alcoholics.
Alcoholism, clinical and experimental research 1992;16(6):1007-13.
1991: Carrie L Randall; Raymond F Anton; Howard C Becker; R L Hale; U Ekblad
Aspirin dose-dependently reduces alcohol-induced birth defects and prostaglandin E levels in mice.
Teratology 1991;44(5):521-9.
1991: Carrie L Randall; Howard C Becker; Raymond F Anton
Effect of ibuprofen on alcohol-induced teratogenesis in mice.
Alcoholism, clinical and experimental research 1991;15(4):673-7.
1991: A L Johnston; A K Thevos; Carrie L Randall; Raymond F Anton
Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis.
British journal of addiction 1991;86(6):719-25.
1990: Carrie L Randall; U Ekblad; Raymond F Anton
Perspectives on the pathophysiology of fetal alcohol syndrome.
Alcoholism, clinical and experimental research 1990;14(6):807-12.
1990: Kathleen T Brady; Raymond F Anton; J C Ballenger; R B Lydiard; B Adinoff; J Selander
Cocaine abuse among schizophrenic patients.
The American journal of psychiatry 1990;147(9):1164-7.
1990: Raymond F Anton; E A Burch
Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.
The American journal of psychiatry 1990;147(9):1203-8.
1990: Howard C Becker; Raymond F Anton
Valproate potentiates and picrotoxin antagonizes the anxiolytic action of ethanol in a nonshock conflict task.
Neuropharmacology 1990;29(9):837-43.
1990: Raymond F Anton; Howard C Becker; Carrie L Randall
Ethanol increases PGE and thromboxane production in mouse pregnant uterine tissue.
Life sciences 1990;46(16):1145-53.
1990: M L Willenbring; Raymond F Anton; W D Spring; R B Shafer; W Dorus
Thyrotropin and prolactin response to thyrotropin-releasing hormone in depressed and nondepressed alcoholic men.
Biological psychiatry 1990;27(1):31-8.
1989: W Dorus; D G Ostrow; Raymond F Anton; P Cushman; J F Collins; M Schaefer; H L Charles; P Desai; M Hayashida; U Malkerneker
Lithium treatment of depressed and nondepressed alcoholics.
JAMA : the journal of the American Medical Association 1989;262(12):1646-52.
1989: Raymond F Anton; James C Ballenger; R Bruce Lydiard; M T Laraia; E F Howell; P W Gold
CSF prostaglandin-E in agoraphobia with panic attacks.
Biological psychiatry 1989;26(3):257-64.
1989: Robert Malcolm; James C Ballenger; E T Sturgis; Raymond F Anton
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal.
The American journal of psychiatry 1989;146(5):617-21.
1989: Kathleen T Brady; Raymond F Anton
The thyroid axis and desipramine treatment in depression.
Biological psychiatry 1989;25(6):703-9.
1989: Carrie L Randall; Raymond F Anton; Howard C Becker; N M White
Role of prostaglandins in alcohol teratogenesis.
Annals of the New York Academy of Sciences 1989;562():178-82.
1989: Howard C Becker; Raymond F Anton
The benzodiazepine receptor inverse agonist RO15-4513 exacerbates, but does not precipitate, ethanol withdrawal in mice.
Pharmacology, biochemistry, and behavior 1989;32(1):163-7.
1988: Raymond F Anton; Carrie L Randall; Howard C Becker
PGE measurement in mouse embryos and uterine/embryo tissue.
Prostaglandins 1988;36(6):835-46.
1988: Carrie L Randall; Raymond F Anton; Howard C Becker
Role of alcohol-induced hypothermia in mediating the teratogenic effects of alcohol in C57BL/6J mice.
Alcoholism, clinical and experimental research 1988;12(3):412-6.
1988: M E Brown; Raymond F Anton; Robert Malcolm; James C Ballenger
Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis.
Biological psychiatry 1988;23(5):507-14.
1987: Howard C Becker; Raymond F Anton; Carrie L Randall
Stereotypic wall climbing in mice during ethanol withdrawal: a new measure of physical dependence.
Alcohol (Fayetteville, N.Y.) 1987;4(6):443-7.
1987: Carrie L Randall; Raymond F Anton; Howard C Becker
Effect of indomethacin on alcohol-induced morphological anomalies in mice.
Life sciences 1987;41(3):361-9.
1987: Carrie L Randall; Raymond F Anton; Howard C Becker
Alcohol, pregnancy, and prostaglandins.
Alcoholism, clinical and experimental research 1987;11(1):32-6.
1987: Raymond F Anton; Carrie L Randall
Central nervous system prostaglandins and ethanol.
Alcoholism, clinical and experimental research 1987;11(1):10-8.
1987: Raymond F Anton
Urinary free cortisol in psychotic depression.
Biological psychiatry 1987;22(1):24-34.
1986: Raymond F Anton; L Randolph Waid; M Fossey; P AuBuchon
Case report of carbamazepine treatment of organic brain syndrome with psychotic features.
Journal of clinical psychopharmacology 1986;6(4):232-4.
1986: Howard C Becker; Carrie L Randall; Raymond F Anton
Pre-pregnancy alcohol experience attenuates typical decrease in gestational alcohol consumption in mice.
Alcohol (Fayetteville, N.Y.) 1986;3(1):19-22.
1985: Howard C Becker; Raymond F Anton; C De Trana; Carrie L Randall
Sensitivity to ethanol in female mice: effects of ovariectomy and strain.
Life sciences 1985;37(14):1293-300.
1985: G C Johnson; Raymond F Anton
Delusions of parasitosis: differential diagnosis and treatment.
Southern medical journal 1985;78(8):914-8.
1985: Raymond F Anton; J A Paladino; A Morton; R W Thomas
Effect of acute alcohol consumption on lithium kinetics.
Clinical pharmacology and therapeutics 1985;38(1):52-5.
1984: Carrie L Randall; Raymond F Anton
Aspirin reduces alcohol-induced prenatal mortality and malformations in mice.
Alcoholism, clinical and experimental research 1984;8(6):513-5.
1984: C J Wallis; Raymond F Anton; Carrie L Randall
Adrenalectomy reduces alcohol-stimulated activity: blood and brain alcohol content.
Pharmacology, biochemistry, and behavior 1984;20(6):883-6.
1983: Raymond F Anton; James D. Sexauer; Carrie L Randall
Amoxapine elevates serum prolactin in depressed men.
Journal of affective disorders 1983;5(4):305-10.
1983: Raymond F Anton; James D. Sexauer
Efficacy of amoxapine in psychotic depression.
The American journal of psychiatry 1983;140(10):1344-7.
1983: G C Johnson; Raymond F Anton
Pimozide in delusions of parasitosis.
The Journal of clinical psychiatry 1983;44(6):233.
1983: Carrie L Randall; S S Hughes; C K Williams; Raymond F Anton
Effect of prenatal alcohol exposure on consumption of alcohol and alcohol-induced sleep time in mice.
Pharmacology, biochemistry, and behavior 1983;18 Suppl 1():325-9.
1983: Raymond F Anton; Carrie L Randall; C K Williams; G E Hoffmeyer
Inhibition of prostaglandin synthesis by indomethacin does not affect alcohol consumption in inbred mice.
Alcoholism, clinical and experimental research 1983;7(4):386-8.
1981: Raymond F Anton; I Hogan; B Jalali; C E Riordan; H D Kleber
Multiple family therapy and naltrexone in the treatment of opiate dependence.
Drug and alcohol dependence 1981;8(2):157-68.